ReBlood Rx
PrivateLast Round
Grant
Jan 1, 2026
Total Funding Raised
$402,000
Company Overview
ReBlood Rx is a biotechnology company that develops hemoglobin-based oxygen carriers (HBOCs) to provide safe and efficient oxygen delivery solutions for medical emergencies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ReBlood Rx Comparables
Compare ReBlood Rx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| VirTech Bio | 91% | |
| KaloCyte, Inc. | 84% | |
| OxyVita Inc. | 80% | |
ReBlood Rx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 1, 2026 | ||||
| Seed | Aug 4, 2025 | ||||
| Grant | Aug 4, 2025 | ||||
| Accelerator | Aug 19, 2024 | ||||
| Grant | Jul 1, 2024 |
ReBlood Rx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DIANA | Grant |
| 757 Collab | Accelerator |
| 757 Accelerate | Accelerator |
| rpv | Seed |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 11, 2024
Monthly visitors grew 244% MoM, reaching 447.
- Aug 19, 2024
$20K raised from 757 Accelerate and 757 Collab.
ReBlood Rx Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ReBlood Rx's valuation, stock price, and market status.